• Issue

    British Journal of Haematology: Volume 155, Issue 5

    535-642
    December 2011
Previous Issue|Next Issue
Export Citation(s)Download PDF(s)

Images in Haematology

Acute lymphoblastic leukaemia in a patient with osteopoikilosis

Kalina Brandt,  Jörn Meinel,  Michael Laniado,  Markus Schaich, 
  • Page: 535
  • First Published: 19 July 2011

Bilateral subdural hygromas following intrathecal methotrexate

Padmaja Lokireddy,  Martin J. S. Dyer, 
  • Page: 536
  • First Published: 19 September 2011

Reviews

Management of major trauma haemorrhage: treatment priorities and controversies

Ross Davenport,  Sirat Khan, 
  • Pages: 537-548
  • First Published: 21 October 2011

Management of osteonecrosis in children and young adults with acute lymphoblastic leukaemia

Ajay Vora, 
  • Pages: 549-560
  • First Published: 21 September 2011

The potential role of Aurora kinase inhibitors in haematological malignancies

Sherif S. Farag, 
  • Pages: 561-579
  • First Published: 08 October 2011

Haematological Malignancy

A modified regimen of pegylated liposomal doxorubicin, bortezomib and dexamethasone (DVD) is effective and well tolerated for previously untreated multiple myeloma patients

James R. Berenson,  Ori Yellin,  Chien-Shing Chen,  Ravi Patel,  Alberto Bessudo,  Ralph V. Boccia,  Hank H. Yang,  Robert Vescio,  Elizabeth Yung,  Russell Mapes,  Benjamin Eades,  James D. Hilger,  Eric Wirtschafter,  Jacqueline Hilger,  Youram Nassir,  Regina A. Swift, 
  • Pages: 580-587
  • First Published: 26 September 2011

Preclinical evaluation of a novel SIRT1 modulator SRT1720 in multiple myeloma cells

Dharminder Chauhan,  Madhavi Bandi,  Ajita V. Singh,  Arghya Ray,  Noopur Raje,  Paul Richardson,  Kenneth C. Anderson, 
  • Pages: 588-598
  • First Published: 26 September 2011

Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme

Lieke H. van der Helm,  Canan Alhan,  Pierre W. Wijermans,  Marinus van Marwijk Kooy,  Ron Schaafsma,  Bart J. Biemond,  Aart Beeker,  Mels Hoogendoorn,  Bastiaan P. van Rees,  Okke de Weerdt,  Jurgen Wegman,  Ward J. Libourel,  Sylvia A. Luykx-de Bakker,  Monique C. Minnema,  Rolf E. Brouwer,  Fransien Croon-de Boer,  Matthijs Eefting,  Kon-Siong G. Jie,  Arjan A. van de Loosdrecht,  Jan Koedam,  Nic J. G. M Veeger,  Edo Vellenga,  Gerwin Huls, 
  • Pages: 599-606
  • First Published: 08 October 2011

Editorial Comment

A defining moment for hairy cell leukaemia

Rebecca L. Auer,  Finbarr E. Cotter, 
  • Pages: 607-608
  • First Published: 19 September 2011

Haematological Malignancy

High resolution melting analysis for detection of BRAF exon 15 mutations in hairy cell leukaemia and other lymphoid malignancies

Elaine M. Boyd,  Anthony J. Bench,  Mars B. van ‘t Veer,  Penny Wright,  David M. Bloxham,  George A. Follows,  Mike A. Scott, 
  • Pages: 609-612
  • First Published: 13 September 2011

Platelets, Haemostasis and Thrombosis

Cumulative flying time and risk of venous thromboembolism

Peter K. MacCallum,  Deborah Ashby,  Enid M. Hennessy,  Louise Letley,  Jeannett Martin,  Shahrul Mt-Isa,  Madge R. Vickers,  Ken Whyte, 
  • Pages: 613-619
  • First Published: 08 October 2011

Correspondence

Free Access

B cell activating factor is elevated in acute idiopathic thrombotic thrombocytopenic purpura

Mari R. Thomas,  Samuel J. Machin,  Ian Mackie,  Marie A. Scully, 
  • Pages: 620-622
  • First Published: 25 May 2011
Free Access

Acquired von Willebrand Syndrome in congenital heart disease: does it promote an increased bleeding risk?

Grace Onimoe,  Linda Grooms,  Kami Perdue,  Frederick Ruymann, 
  • Pages: 622-624
  • First Published: 14 May 2011
Free Access

Steroids in neutropenic patients with sepsis – comment on How I manage haematology patients with septic shock by Jon Cohen and Stephen Drage

Maximilian Christopeit,  Olaf Penack,  Helmut Ostermann, 
  • Pages: 624-625
  • First Published: 12 May 2011
Free Access

Steroids in neutropenic patients with sepsis – response to Christopeit et al

Jon Cohen,  Stephen Drage, 
  • Pages: 625-626
  • First Published: 12 May 2011
Free Access

Mitochondrial genome variants in non-remitting ALL of childhood

Christina Back,  Helgard Knauß,  Wolf-Dieter Ludwig,  Martin Schrappe,  Klaus-Michael Debatin,  Christian Beltinger, 
  • Pages: 626-629
  • First Published: 25 May 2011
Free Access

Stability of low molecular weight heparin anti-factor Xa activity in citrated whole blood and plasma

Nicole Birri,  Daniela Baumgartner,  Tiziana Conte,  Anh Huynh,  Katja Weller,  Marko Pavicic,  Marianne Reusser,  Ilse Siegenthaler,  Gabriela Barizzi,  Lorenzo Alberio, 
  • Pages: 629-631
  • First Published: 25 May 2011
Free Access

Bendamustine in combination with thalidomide and dexamethasone is an effective therapy for myeloma patients with end stage renal disease

Karthik Ramasamy,  Beth Hazel,  Shameem Mahmood,  Sophie Corderoy,  Stephen Schey, 
  • Pages: 632-634
  • First Published: 21 June 2011
Free Access

Anti-haemolytic effect of senicapoc and decrease in NT-proBNP in adults with sickle cell anaemia

Caterina P. Minniti,  Jonathan Wilson,  Laurel Mendelsohn,  Greg C. Rigdon,  Jonathan W. Stocker,  Alan T. Remaley,  Gregory J. Kato, 
  • Pages: 634-636
  • First Published: 08 June 2011
Free Access

Senicapoc trial results support the existence of different sub-phenotypes of sickle cell disease with possible drug-induced phenotypic shifts

Oswaldo L. Castro,  Victor R. Gordeuk,  Mark T. Gladwin,  Martin H. Steinberg, 
  • Pages: 636-638
  • First Published: 07 July 2011
Free Access

Bone morphogenetic protein-4 (BMP4) up regulates key haematopoietic genes in differentiating embryonic stem cells treated with BMP4 short hairpin RNA

Anil Abeyewickreme,  Adrian J. Thrasher,  Christine Kinnon, 
  • Pages: 638-641
  • First Published: 12 July 2011

Corrigendum

Free Access

Corrigendum

  • Page: 642
  • First Published: 12 November 2011